Purpose. Enterococcus faecalis is commonly found as a commensal gut bacteria, but some linages have caused increasing extra-gastrointestinal infections. In particular, strains with high-level virulence or antimicrobial resistance are prevalent in healthcare settings as nosocomial pathogens. This study was performed to elucidate the epidemiological characteristics and antimicrobial susceptibility profiles of E. faecalis causing nosocomial infections in a Chinese general hospital over a 4-year period.
INTRODUCTION
Enterococcus faecalis, a Gram-positive bacterium, is commonly found as a commensal organism in the gastrointestinal tracts of most mammals. Previously, E. faecalis was considered to be a probiotic, and was widely used in the dairy industry for food fermentation and flavour production [1] . When recombined with different genomic islands from other species [2] , E. faecalis is known for its considerable ability to adapt to the environment. However, some strains show high virulence, with pathogenicity islands (PAIs) in the flexible genome [3] , as first reported by Shankar et al. in 2002 [4] . It has also caused increasing numbers of extra-gastrointestinal infections, especially in immunocompromised patients in hospitals, including urinary tract infections, bacteraemia, and endocarditis [5] . Therefore, E. faecalis is now also considered to be a nosocomial pathogen in healthcare settings [6] .
With regard to the treatment of E. faecalis infections, one of the most important threats to public health is the antimicrobial resistance (AMR), and even multi-drug resistance (MDR), exhibited by a few strains, which has been widely reported globally [5, 7, 8] . In particular, vancomycinresistant enterococci (VRE) have been found in many countries [9] [10] [11] [12] , which makes the treatment of enterococcal infections more difficult. In addition, epidemiological data suggest that E. faecalis is an important reservoir for the transmission of resistant genes among different species of bacteria [2, 13] . Once these genes break through the bottleneck of species limitations, they will decrease the efficiency of broader spectrum antibacterial and/or combination antibacterial therapy for hospital-or community-acquired infections involving other pathogens.
Given the remarkable genomic diversity and plasticity of E. faecalis, comprehensive estimation of the risk and continuous surveillance of AMR among different subtypes or lineages are also urgent. Molecular typing methods have been widely used for the subtyping of bacterial species and to estimate the genetic relationships among isolates from different sources, including multilocus sequence typing (MLST) and multilocus variable-number tandem repeat analysis (MLVA) [14, 15] . The MLST for E. faecalis is based on the use of seven housekeeping genes, gdh, gyd, pstS, gki, aroE, xpt and yqil, to assign the sequence types (STs), followed by analyses of clustering in different clonal complexes (CCs). MLVA can be used for more detailed analysis of the relationships between isolates, and presents higher discriminatory power, especially for isolates obtained over a short period, because the number of repeat units of the variable number of tandem repeats (VNTRs) used for MLVA can vary quickly.
Using these two methods, we can source the relationships among the isolates and illustrate the population structure clearly. Previous MLST analyses showed that CC2, CC9 and CC16 have been the most prevalent clusters associated with healthcare-associated infections (HAIs) throughout the world, most notably in the hospital environment [16] [17] [18] , while CC87 was widely distributed in hospitals in Europe and the United States [19, 20] . In addition, several other STs and CCs associated with human infections have been reported in Asia-Pacific countries, such as ST410 and ST4 of CC4 [21, 22] . However, most studies have focused on the superbug, VRE, and only a limited number of studies have reported the AMR patterns of other strains, which are also important for treatment.
In the clinic, the threat of MDR E. faecalis-associated opportunistic and nosocomial infections is urgent. Considering the variation in virulence of the strains, as well as the different immune conditions of patients, it is hard to estimate the risk, to identify the occurrence of nosocomial infections caused by E. faecalis and to implement specific treatment procedures in time, especially with little prior knowledge of the epidemiological characteristics and AMR profiles of the prevalent subtypes. Therefore, in this study, we selected 77 E. faecalis isolates from our hospital that caused extra-gastrointestinal tract infections, after excluding those sampled from faeces. We identified their population structures and AMR profiles, as well as the AMR patterns among different clusters, in order to understand the epidemiological characteristics of the strains associated with nosocomial infections. We identified the emergence of CC4, which was of higher risk to elderly patients and had higher resistance levels. We also identified an isolate with low-level vancomycin resistance, and observed increasing resistance to linezolid. Through this hospital-based study, we investigated the AMR characteristics of the prevalent E. faecalis subtypes involving nosocomial infections, which is valuable for further studies and for the treatment of the infections.
METHODS
Clinical data and bacterial strains We collected 77 E. faecalis isolates causing extra-gastrointestinal infections from patients in 14 different wards of a tertiary hospital in Beijing, People's Republic of China for our study between January 2011 and December 2014. The clinical data for these patients, including age, sex and ward, were obtained retrospectively by reviewing their medical records ( Table 1) . We only enrolled the isolates cultured from normally sterile sites, such as blood, urine, bile, ascites and secreta. Duplicate isolates from the same patient and those from faeces were excluded from the study. All of the isolates were purified and cultured in brain heart infusion (BHI) medium (Oxoid Ltd, Hampshire, UK) at 37 C for 16 h, and then used in the subsequent analyses. 
DNA isolation and identification of E. faecalis
Genomic DNA was extracted with a QIAamp DNA Mini kit (Qiagen, Hilden, Germany) according to the manufacturer's directions. The identification of the isolates was conducted using both the Automated Microbiology System (BD PhoenixÀ100; BD Biosciences, San Jose, CA, USA) [23] and PCR amplification and sequencing of the 16S rRNA gene (16S rDNA). The 16S rDNA primers (27F: 5¢-AGAG TTTGATCCTGGCTCAG-3¢ and 1492R: 5¢-GGTTACC TTGTTACGACTT-3¢) were used to amplify the sequences, which were subsequently sequenced by Sanger sequencing on an ABI3730 machine (Applied Biosystems, Foster City, CA, USA).
Molecular subtyping by MLST and MLVA MLST was carried out according to the scheme described previously [14] . The seven E. faecalis housekeeping genes, gdh, gyd, pstS, gki, aroE, xpt and yqil, were amplified by PCR using the recommended primers and experimental protocols. The E. faecalis MLST scheme and allele definition, the sequences of the PCR primers, and the PCR conditions are available on the pubMLST website (https://pubmlst.org/ efaecalis/). New alleles and profiles were deposited in the database to obtain new allele and ST numbers. The genetic relationships among the STs were analysed by constructing a minimal spanning tree using PHYLOViZ 2.0 software [24] . MLVA was performed based on analysis of the number of repeat units present at seven VNTR loci (aceB, espA, espC, efa2, efa3, efa5 and efa6) of the E. faecalis genome [15] . The primers described were used for the amplification, and the PCR was carried out using an initial denaturation at 94 C for 5 min, and 15 cycles of 94 C for 30 s, 55 C for 1 min and 72 C for 2 min. The annealing temperature for the first cycle was 70 C and this was decreased by 1 C at each cycle during the next 15 cycles. The sizes of the PCR products were detected by electrophoresis on 1 % agarose gels, together with the standard DNA markers. The MLVA subtypes were then determined by the number of repeat units at the seven VNTR loci. The genetic relationships among subtypes were analysed by constructing a minimal spanning tree using PHYLOViZ 2.0 software [24] .
Antimicrobial susceptibility tests
To evaluate the antimicrobial susceptibility of the E. faecalis isolates, the Kirby-Bauer disk diffusion method was used as described by Lalitha et al. [25] , with a standardized single disk on Muller-Hinton agar. Antimicrobial agents that have been used frequently in previous reports and in the clinic were used for the tests as follows: ampicillin (10 µg); linezolid (30 µg); nitrofurantoin (300 µg); vancomycin (30 µg); teicoplanin (30 µg); tetracycline (30 µg); rifampin (5 µg); erythromycin (15 µg); ciprofloxacin (30 µg); chloramphenicol (30 µg); and high-level gentamicin resistance (HLGR) (120 µg). The results were interpreted according to the 2015 edition of the Clinical and Laboratory Standards Institute guidelines. E. faecalis ATCC 19433 and E. faecalis ATCC 29212 were used for quality control.
Clustering of AMR groups and statistical analyses
The isolates were clustered on the basis of the AMR profiles and a heatmap was generated using the heatmap package in R software. Based on relative frequencies, the AMR patterns were analysed for descriptive purposes. The significance of the difference in the number agents to which resistance is shown by different CCs, and the difference in ages between the patient groups infected by different CCs, was assessed using Student's t-test, and a value of P<0.05 was considered significant.
RESULTS
Prevalence of nosocomial infection caused by E. faecalis We performed continuous surveillance of nosocomial infections caused by E. faecalis from January 2011 to December 2014. To exclude commensal strains, only cases of extragastrointestinal infections were enrolled. Isolates from faecal samples were avoided, and those from urine, blood, ascites, bile and other tissues without commensal bacterial flora were collected (Table 1 ). In total, we obtained 77 isolates from 77 patients, comprising 49 male patients (63.6 %) and 28 female patients (36.4 %). In these cases, E. faecalis was not a colonizer, but was considered to be the causative agent of nosocomial infection, and may have been translocated from faeces or acquired from hospital environments during hospitalization, because no other bacterial species were isolated from the same source. More than half of the patients (43/77, 55.8 %) were over 60 years of age (Table 1 ). We also identified three patients, who were under the age of 30, with human immunodeficiency virus (HIV) infection. The primary diseases of the patients included cirrhosis, cerebral infarction, obstructive jaundice and pancreatitis.
Antimicrobial resistance and patterns
To evaluate the resistance levels of the E. faecalis isolates collected, we performed susceptibility tests on the 77 E. faecalis against 11 different antimicrobial agents in 10 categories using the Kirby-Bauer method. All of the isolates showed high-level resistance to the remaining five antibiotics: tetracycline (88.3 %), rifampin (63.6 %), erythromycin (79.2 %), HLGR (45.4 %) and ciprofloxacin (35 %) ( Table 2) . None of the isolates were resistant to nitrofurantoin, teicoplanin, linezolid, ampicillin, or vancomycin, with the exception of one strain that was resistant to ampicillin. Notably, we also identified that strain S3368 exhibited low-level vancomycin resistance, and another six strains exhibited lowlevel linezolid resistance. Furthermore, MDR strains were widely observed: 96.1 % isolates were resistant to at least three different classes of antibiotic, with 41.6 % of isolates being resistant to five or more antibiotics.
The isolates were clustered on the basis of their AMR profiles and 10 typical groups with different AMR patterns were observed and named patterns I to X; they contained 2-12 isolates each and covered most of the isolates (60, 78 %) in total (Table 3 , Fig. 1 
Sequence types of E. faecalis associated with nosocomial infection
To elucidate the population structure of the prevalent subtypes, we performed MLST and MLVA on the 77 E. faecalis isolates. The MLST analyses showed that our isolates were different from those in previous reports. We identified 10 new alleles in the 7 housekeeping genes and 13 new STs, ST721-ST727 and ST742-ST747, which were assigned by the pubMLST database. In addition, we also identified five new STs of new combinations of known alleles. Finally, we identified 29 STs in our study, including 18 novel STs. Four STs were dominant groups comprising 49.4 % of the isolates; 23.4 % of the isolates were ST16, 11.7 % were ST179, 9.1 % were ST4 and 7.8 % were ST724. Of these STs, ST179 and ST16 belonged to the same CC, named CC16, as in a previous report [5] . ST724 was a new ST, and ST4 belonged to another CC, named CC4.
Given the large genomic diversity in E. faecalis, we performed eBURST analyses, and grouped the 77 isolates of the 29 STs. Three major CCs were identified, including CC4, CC16 and CC21, covering most of the isolates (45, 58.4 %) (Fig. 2a) . CC4 included three major STs, ST4, and two additional newly identified STs, ST723 and ST724, covering 14 isolates. CC16 contained ST179 and ST16, which were widespread in the clinic, covering 27 isolates. However, CC21 only contained four isolates of three STs, ST21, ST22 and ST145. Thus, CC4 and CC16 were the major groups involved in nosocomial infection in our hospital and covered 53.2 % of the isolates in our study. Meanwhile, the isolation rate for CC4 increased in this 4-year period, from 7.5 % in 2011 to 25 % after 2012, while that of CC21 increased slightly but continuously after 2012, but the rate for CC16 decreased continuously from 45 % in 2011 to 25 % in 2014 (Fig. 3a) . Therefore, these results indicated that although CC16 was still the most prevalent cluster, the composition of the dominant subtypes has changed recently. The other two CCs, and CC4 in particular, may be newly emerging complexes in the hospital.
To further explore the phylogenetic relationships of the isolates in these two major CCs, we performed MLVA on our isolates. Fourteen isolates in CC4 were divided into 14 MLVA types, while 28 isolates in CC16 were divided into 20 MLVA types (Fig. 2b) . This showed that the isolates in these groups were scattered in the map of MLVA patterns, although they were of the same STs. Given that these isolates were obtained from different wards in the hospital, we suspect that these isolates showed long-term persistence there, and occasionally infected the patients, but not in the form of an outbreak.
AMR patterns among STs
To investigate the AMR profiles and patterns among different STs, we categorized the 77 strains according to STs and CCs, and mapped the AMR characteristics and patterns to these groups. S3368, with low-level resistance to vancomycin, belonged to ST722, which was not clustered in any CCs. CC4, with a high rate of resistance, was mainly distributed in two resistance patterns: eight isolates in pattern III and two in pattern II (Fig. 1) . We also compared the rate of resistance against six agents in our isolates, because resistance to the other five agents was rare. The data showed that CC4 had higher rates of resistance against erythromycin, ciprofloxacin, HLGR and tetracycline, while CC16 had a higher rate of resistance against rifampin (Fig. 3b) . In addition, CC4 showed resistance to more agents than CC16 (Fig. 3c) , and the patients infected by CC4 were much older than the others (Fig. 3d) . Thus, we assumed that CC4, with a much higher potential risk of infection in elderly patients, would cause treatment problems in the clinic, and cause further outbreaks of HAIs.
DISCUSSION
E. faecalis has been considered to be a natural colonizer of the gastrointestinal tract in most humans and other animals, and was rarely observed in other samples, such as blood, urine, bile and ascites [26] . However, it can enter other parts of the body and cause infections when patients are hospitalized in critical care units, or are immunosuppressed, and are given multiple antimicrobial agents, resulting in a decline in the body's immunity [27] . In this study, we obtained E. faecalis isolates continuously in the hospital over four years, all of which were cultured from sterile sources and caused HAIs. We performed a molecular epidemiological study to elucidate the prevalence of different subtypes, and used antimicrobial susceptibility tests to elucidate the AMR characteristics. These results will facilitate our understanding of the resistance patterns of the prevalent E. faecalis subtypes and be helpful for the treatment of patients. For example, the resistance rates for rifampin (63.6 %), erythromycin Based on the distances between the clusters, we grouped all of the isolates manually into 10 patterns ( Table 2 ). The sources, STs and resistance patterns of the isolates are listed on the right. Yellow circles, urine; black circles, blood; green circles, bile; purple circles, ascites; white circles, secreta.
(79.2 %) and tetracycline (88.3 %) were extremely high within our isolates, whereas almost all of these isolates were susceptible to ampicillin, vancomycin, nitrofurantoin and teicoplanin, and this information will help to guide antimicrobial treatments in the clinic.
In North America and Europe, CC2 and CC9 are the two major groups derived from hospitals [28] ; they have been called high-risk enterococcal CCs (HiRECCs) [16] . For example, the well-known resistant strain E. faecalis V583 belongs to CC2, and was considered to be involved in serious invasive infections such as septicaemia and endocarditis, while CC9 was considered to be related to penicillinase production [29] . Another widespread cluster, CC16 (ST16), an MDR subtype, has been isolated from clinical infections and the intestinal colonization of hospital patients or healthy volunteers, as well as other animals, and has been widely reported in many regions, including Europe and Asia [5, 8, 30, 31] . In our study, the findings were consistent with these reports: ST16 isolates were identified in almost all of the wards and all types of sample, and CC16 was the dominant subtype in all of the 4 years. However, we also noticed that the isolation rate for CC16 decreased continually. In contrast, we observed that the isolation rates for CC4 (ST4, together with a newly identified sequence type, ST724) and CC21 (ST21, ST22 and ST145) increased; by 2014 the proportion of these two CCs was more than three times what it had been in 2011. In particular, CC4 became the other dominant subtype alongside CC16 in 2014, and was of the same prevalence as CC16. In addition, CC4 was of high risk to immunocompromised patients, and showed higher resistance rates against various antimicrobial agents than the other STs. Of the 77 isolates identified, ST724 of CC4 was the only one that presented high-level ampicillin resistance. The isolates of CC4 were resistant to 5.4 categories of agents within the 10 we used in average, which is significantly higher than the figures for CC16 and the other CCs (Fig. 3c) . All of these findings showed that CC4 may be a newly emerging high-risk MDR cluster. Meanwhile, this subtype has recently been reported as causing sporadic cases of nosocomial infection in Asia-Pacific countries, e. g. China [21, 22] , Japan [32] and Malaysia [33] , but rare in other regions, indicating that further study and surveillance are needed.
A vancomycin-resistant strain, E. faecalis V583, known as the first vancomycin-resistant enterococci (VRE) isolated in the United States [34] , has crossed last-line drugs, and belongs to ST6, CC2. In our study, we obtained a low-level vancomycin-resistant strain, S3368, which belonged to the newly identified ST722. Given that E. faecalis contains more than 25 % mobile genome sequences and various conjugative plasmids [35] [36] [37] , this isolate may acquire vancomycin resistance via horizontal gene transfer from other vancomycin-resistant STs. This is consistent with the reports suggesting that new subtypes of VRE are continually emerging [38] [39] [40] . In addition, it is noteworthy that linezolid, a member of the oxazolidinone class of antibiotics that was first introduced to China in 2007 [41] , was also observed to have low-level resistance in six isolates. Molecular epidemiological analyses of these strains are also needed to investigate the situation regarding resistance to linezolid in China.
In conclusion, we elucidated the molecular epidemiological characteristics and AMR patterns among prevalent E. faecalis in our hospital from a continuous surveillance. We described three major groups, CC16, CC4 and CC21, which were the dominant clusters in recent years, of which CC4 may be a newly emerging, high-risk MDR cluster. These results will increase our understanding of the prevalence of E. faecalis isolates causing nosocomial infection, and provide further assistance for prevention and treatment in the clinic.
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